A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Weight-loss jabs have grown massively in popularity over the past year, but a team of scientists has now found that the injections are less effective in real life than in clinical trials.

Barkley has worked hard on his weight loss, and he’s a lot more confident about his physique now. The TNT NHL crew acknowledged that the NBA legend has shed a significant amount of weight, which helps ...

Lilly to Offer Highest Doses of Weight-Loss Drug Zepbound on Website (Reuters) -Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its ...

Need to Know He spotted weight-loss drugs and AI before they became hot. Here’s this investor’s next big idea. Citrini Research’s James van Geelen sees future robots cleaning your house ...

Glucagon-like peptide-1 agonists are a class of medications historically used to treat type 2 diabetes and manage blood sugar. In recent years, some of these drugs have also been approved to treat ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect may not ...

People facing weight stigma are more likely to have a harder time exercising and making changes to their nutrition, new research shows.

Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United States. In May 2024, ...